GX-C4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGX-C4

Drug Alias NameCTLA-4/Fc region of a hybrid IgG4/IgD antibody (Genexine)GX-C4

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 modulators

TargetsCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGannex Pharma Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGannex Pharma Co Ltd

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A